Exosome therapeutics for COVID‐19 and respiratory viruses-Reference-Cited by-同舟云学术

Exosome therapeutics for COVID‐19 and respiratory viruses

Published:2021-01-31 Issue:3 Volume:2 Page:20200186
ISSN:2688-268X
Container-title:VIEW
language:en
Short-container-title:VIEW

Author:

Popowski Kristen D.¹²^ORCID,Dinh Phuong‐Uyen C.¹²^ORCID,George Arianna³⁴^ORCID,Lutz Halle¹²^ORCID,Cheng Ke¹²⁵⁶^ORCID

Affiliation:

1. Department of Molecular Biomedical Sciences North Carolina State University Raleigh North Carolina USA

2. Comparative Medicine Institute North Carolina State University Raleigh North Carolina USA

3. Department of Molecular and Structural Biochemistry North Carolina State University Raleigh North Carolina USA

4. Department of Biological Sciences North Carolina State University Raleigh North Carolina USA

5. Joint Department of Biomedical Engineering University of North Carolina at Chapel Hill and North Carolina State University Raleigh/Chapel Hill North Carolina USA

6. Division of Pharmacoengineering and Molecular Pharmaceutics University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Funder

National Institutes of Health

American Heart Association

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/VIW.20200186

Reference73 articles.

1. Transmission routes of respiratory viruses among humans

2. Drivers of airborne human-to-human pathogen transmission

3. A Novel Coronavirus from Patients with Pneumonia in China, 2019

4. Vaccine approaches conferring cross-protection against influenza viruses

5. Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Engineering Planar Model Cell Membranes: Current Techniques, Applications, and Future Perspectives;Nanomaterials;2024-09-13

2. Exosomes: Friends or Foes in Microbial Infections?;Infectious Disorders - Drug Targets;2024-08

3. Exosomes, and the potential for exosome‐based interventions against COVID‐19;Reviews in Medical Virology;2024-06-25

4. A Narrative Review on the Management of Severe COVID-19 Infection Using Stem Cell-based therapies with a Focus on the Registered Clinical Trials;Qeios;2024-03-26

5. Challenges of mesenchymal stem cells in the clinical treatment of COVID-19;Cell and Tissue Research;2024-03-21